Transcatheter heart valves technologies

Radial versus femoral secondary access for transcatheter aortic valve replacement: A systematic review and meta‐analysis

Published on 20/01/2022 | Thomas M.DasMD 1 et al. | Catheterization and Cardiovascular Interventions 2021; AOP: 10.1002/ccd.30009 | 16 minute read

Abstract Objectives We aimed to evaluate the risk of procedural complications after TAVR using secondary radial access (RA) versus femoral

Transcatheter heart valves technologies

Proposal criteria of paradoxical low-flow low-gradient aortic stenosis for predicting prognosis in patients undergoing transcatheter aortic valve implantation

Published on 20/12/2021 | Tomomi Tanino 1 et al. | Heart and Vessels 2021; aop: 10.1007/s00380-021-01992-y | 21 minute read

Abstract Background Paradoxical low-flow, low-gradient (PLF-LG) aortic stenosis (AS) is associated with poor prognosis in patients undergoing transcatheter aortic valve

Transcatheter heart valves technologies

Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis: a systematic review and meta-analysis

Published on 20/12/2021 | Stephanie Louise Swift 1 et al. | BMJ Open 2021; 11(12): e054222 | 47 minute read

Abstract Objectives Patients undergoing surgery for severe aortic stenosis (SAS) can be treated with either transcatheter aortic valve implantation (TAVI)

Transcatheter heart valves technologies

Transcatheter aortic valve replacement for structural degeneration of previously implanted transcatheter valves (TAVR-in-TAVR): a systematic review

Published on 10/11/2021 | Michele Gallo et al. | European journal of cardio-thoracic surgery 2021; aop: 10.1093/ejcts/ezab443 | 21 minute read

Abstract Objectives Transcatheter aortic valve replacement (TAVR) represents a valid treatment for patients with aortic valve stenosis and high or

Transcatheter heart valves technologies

Trends in utilization, outcomes, and readmissions after transcatheter mitral valve replacement

Published on 10/11/2021 | AymanElbadawiMD 1 et al. | Catheterization and Cardiovascular Interventions 2021; AOP: 10.1002/ccd.29963 | 20 minute read

Abstract Background There is a paucity of real‐world data regarding the temporal trends and outcomes of trans‐septal transcatheter mitral valve

Transcatheter heart valves technologies

Direct transaortic transcather valve-in-valve implantation into a mechanical aortic valve prosthesis during left ventricular assist device implantation: description of a surgical technique

Published on 08/11/2021 | Philipp Kiefer et al. | Interactive CardioVascular and Thoracic Surgery 2021; aop: 10.1093/icvts/ivab253 | 6 minute read

Abstract The presence of a mechanical aortic valve prosthesis is considered a relative contraindication for left ventricular assist device implantation

Transcatheter heart valves technologies

Postprocedural Troponin Elevation and Mortality After Transcatheter Aortic Valve Implantation

Published on 08/11/2021 | Matthias Schindler PhD 1 et al. | Journal of the American Heart Association 2021; 10(21): 020739 | 22 minute read

Abstract Background This study sought to investigate the role of postprocedural troponin elevations in mortality prediction after transcatheter aortic valve

Transcatheter heart valves technologies

Center Variability in Medicare Claims–Based Publicly Reported Transcatheter Aortic Valve Replacement Outcome Measures

Published on 08/11/2021 | Michael P. Thompson PhD 1 et al. | Journal of the American Heart Association 2021; 10(21): 021629 | 23 minute read

Abstract Background Public reporting of transcatheter aortic valve replacement (TAVR) claims–based outcome measures is used to identify high‐ and low‐performing

Transcatheter heart valves technologies

Effects of Statins After Transcatheter Aortic Valve Implantation in Key Patient Populations

Published on 08/10/2021 | Fischer-Rasokat et al. | Journal of Cardiovascular Pharmacology 2021; 78(5): e669-e674 | 13 minute read

Abstract Statin therapy after transcatheter aortic valve replacement (TAVI) is associated with better short-term and long-term outcomes. It is of

Transcatheter heart valves technologies

Impact of Transcatheter Aortic Valve Replacement on Hospitalization Rates: Insights From Nationwide Readmission Database

Published on 08/10/2021 | Ahmed Elkaryoni MD 1 et al. | Journal of the American Heart Association 2021; 10(21): 022910 | 14 minute read

Abstract Background Hospitalization rates after transcatheter aortic valve replacement (TAVR) remain high, given the age and comorbidities of patients undergoing

This bibliographical database is provided by GNM Healthcare Group Companies USA, Inc. in full editorial independence.

The information published within the framework of this service may discuss or suggest certain therapies that have not been validated by the competent national authorities.
Service exclusively reserved for healthcare professionals.